Mint Incorporation Limited Class A Ordinary Shares (MIMI) | Q1 2025 | 1,309,900% |
Propanc Biopharma, Inc Common Stock (PPCB) | Q1 2025 | 916,566.67% |
Haoxi Health Technology Limited Class A Ordinary Shares (HAO) | Q1 2025 | 105,072.5% |
Diginex Limited Ordinary Shares (DGNX) | Q1 2025 | 1,982.16% |
Regencell Bioscience (RGC) | Q1 2025 | 527.45% |
MicroAlgo (MLGO) | Q1 2025 | 419.27% |
Dominari (DOMH) | Q1 2025 | 324.75% |
Lixiang Education (LXEH) | Q1 2025 | 287.4% |
CervoMed (CRVO) | Q1 2025 | 281.25% |
Oncology Institute (TOI) | Q1 2025 | 272.55% |
Vestand (VSTD) | Q1 2025 | 271.52% |
Jiuzi (JZXN) | Q1 2025 | 227.86% |
Rapid Micro Biosystems (RPID) | Q1 2025 | 190.11% |
Eva Live Inc Common Stock (GOAI) | Q1 2025 | 186.43% |
SharonAI Holdings, Inc Class A Common Stock (SHAZ) | Q1 2025 | 185.71% |
FiEE (FIEE) | Q1 2025 | 156.88% |
SuperX AI Technology (SUPX) | Q1 2025 | 147.86% |
Almonty Industries Inc Common Shares (ALM) | Q1 2025 | 145.31% |
Oriental Culture Holding (OCG) | Q1 2025 | 142.86% |
Palvella Therapeutics (PVLA) | Q1 2025 | 141.09% |
Jayud Global Logistics Limited Class A Ordinary Shares (JYD) | Q1 2025 | 136.62% |
Niu Technologies (NIU) | Q1 2025 | 126.67% |
Corcept Therapeutics (CORT) | Q1 2025 | 125.64% |
Park Ha Biological Technology (BYAH) | Q1 2025 | 124.83% |
Neuronetics (STIM) | Q1 2025 | 123.03% |
